Dr. Lao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
B1 floor Cancer Recp C
Ann Arbor, MI 48109Phone+1 734-647-8906
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2001 - 2004
University of Alabama Medical CenterResidency, Internal Medicine, 1998 - 2001
Icahn School of Medicine at Mount SinaiClass of 1998
Certifications & Licensure
MI State Medical License 2001 - 2026
AL State Medical License 1999 - 2001
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Dinaciclib in Treating Patients With Stage IV Melanoma Start of enrollment: 2009 Jul 01
- PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy Start of enrollment: 2011 Aug 01
- HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMa...Raymond Y Huang, Gilbert Youssef, Thomas Nelson, Patrick Y Wen, Peter Forsyth
Journal of Clinical Oncology. 2025-01-03 - 12 citationsFinal, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.Jedd D Wolchok, Vanna Chiarion-Sileni, Piotr Rutkowski, C Lance Cowey, Dirk Schadendorf
The New England Journal of Medicine. 2025-01-02 - 1 citationsSouthwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma.Christopher D Lao, James Moon, Vincent T Ma, John P Fruehauf, Lawrence E Flaherty
Cancer. 2025-01-01
Journal Articles
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the BrainKim Margolin, Omid Hamid, Christopher D Lao, Anna C Pavlick, Michael A Postow, F Stephen Hodi, Nikhil I Khushalani, Marc S Ernstoff, Hussein A Tawbi, Igor Puzanov, Ahm..., The New England Journal of Medicine
Grant Support
- Development Of A Melanoma Chemoprevention ModelNational Cancer Institute2006–2010
- Phase I Single-Dose Safety And Pharmacokinetics Clinical Study Of ResveratrolNational Center For Research Resources2005–2006
- Feasibility Of Barrett?S Esophagus Chemoprev Through Eval Of Esophageal ResectNational Center For Research Resources2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
